Covered recipient · General Payments record
MELLEKATE S VISHWAS
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$5,680.04
- Reported across 230 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,826.42 | 60 |
| Travel and Lodging | $298.21 | 2 |
| Education | $146.72 | 4 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| NEUROPACE, INC. | $684.34 | 8 |
| SK Life Science, Inc. | $224.60 | 7 |
| Neurelis, Inc. | $206.28 | 5 |
| UCB, Inc. | $191.55 | 6 |
| Alexion Pharmaceuticals, Inc. | $90.12 | 4 |
| ARGENX US, INC. | $78.93 | 3 |
| BAXTER HEALTHCARE | $73.69 | 3 |
| CSL Behring | $68.03 | 3 |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $67.91 | 3 |
| Neurocrine BioSciences, Inc. | $64.22 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $61.68 | 2 |
| NS Pharma, Inc. | $57.99 | 3 |
| Sumitomo Pharma America, Inc. | $49.56 | 2 |
| ABBVIE INC. | $46.83 | 2 |
| Sarepta Therapeutics, Inc. | $42.10 | 2 |
| Octapharma USA, Inc. | $40.11 | 1 |
| CATALYST PHARMACEUTICALS, INC. | $35.85 | 1 |
| Biogen, Inc. | $28.25 | 1 |
| Averitas Pharma Inc. | $25.68 | 1 |
| Genentech USA, Inc. | $25.28 | 1 |
| EISAI INC. | $24.63 | 1 |
| Lilly USA, LLC | $21.73 | 1 |
| Marinus Pharmaceuticals, Inc. | $16.96 | 1 |
| PFIZER INC. | $16.47 | 1 |
| Electromed, Inc. | $14.80 | 1 |
| Otsuka America Pharmaceutical, Inc. | $13.76 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (66)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.